AU2003260943A1 - Improved novel, clear, painless preparation of propofol - Google Patents

Improved novel, clear, painless preparation of propofol

Info

Publication number
AU2003260943A1
AU2003260943A1 AU2003260943A AU2003260943A AU2003260943A1 AU 2003260943 A1 AU2003260943 A1 AU 2003260943A1 AU 2003260943 A AU2003260943 A AU 2003260943A AU 2003260943 A AU2003260943 A AU 2003260943A AU 2003260943 A1 AU2003260943 A1 AU 2003260943A1
Authority
AU
Australia
Prior art keywords
propofol
painless
clear
preparation
improved novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003260943A
Inventor
Shashikant Prabhudas Kurani
Dinesh Shantilal Patel
Sachin Dinesh Patel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2003260943A1 publication Critical patent/AU2003260943A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
AU2003260943A 2003-06-10 2003-06-10 Improved novel, clear, painless preparation of propofol Abandoned AU2003260943A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2003/000217 WO2004108113A1 (en) 2003-06-10 2003-06-10 Improved novel, clear, painless preparation of propofol

Publications (1)

Publication Number Publication Date
AU2003260943A1 true AU2003260943A1 (en) 2005-01-04

Family

ID=33495849

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003260943A Abandoned AU2003260943A1 (en) 2003-06-10 2003-06-10 Improved novel, clear, painless preparation of propofol

Country Status (2)

Country Link
AU (1) AU2003260943A1 (en)
WO (1) WO2004108113A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080055804A (en) * 2005-08-12 2008-06-19 바라트 쎄럼스 앤드 백신스 리미티드 Aqueous anaesthetic compositions comprising propofol
CN103877252A (en) * 2014-03-25 2014-06-25 王寿世 Compound preparation for local anaesthesia and preparation method thereof
EP3331567B1 (en) * 2015-07-24 2020-09-23 Neon Laboratories Ltd. Stabilized injectable emulsion of propofol and ketamine
EP3612229A4 (en) 2017-04-19 2020-04-29 Mayo Foundation for Medical Education and Research Ketamine and propofol admixture
WO2020028629A1 (en) * 2018-08-01 2020-02-06 The Regents Of The University Of California Compositions comprising propofol, ketamine, and analgesic, and methods of use
WO2021211575A1 (en) * 2020-04-13 2021-10-21 The Regents Of The Univefisity Of California Compositions comprising propofol, ketamine, and non-opioid analgesic, and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4056637A (en) * 1976-06-08 1977-11-01 Japan Natural Food Co. Ltd. Process for preparing food products containing a lactic acid bacteria-fermented product of a cereal germ
US5962536A (en) * 1998-07-31 1999-10-05 Komer; Gene Injectable propofol formulations
PT1143962E (en) * 1999-01-28 2005-03-31 Kurani Shashikant Prabhudas PARENTERIC SOLUTION OF PROPOFOL (2,6-DI-ISOPROPYLPHENOL) AND 2,5-DI-O-METHYL-1,4, 3,6-DI-ANHYDRO-D-GLUCITOL, AS A DISSOLVENT
US6071933A (en) * 1999-12-03 2000-06-06 Diversified Medical Innovations, Inc. Homogeneous remifentanil-propofol blend for patient controlled anesthesia and process for its use
CA2441744C (en) * 2001-03-20 2011-07-12 Cydex, Inc. Formulations containing propofol and a sulfoalkyl ether cyclodextrin

Also Published As

Publication number Publication date
WO2004108113A1 (en) 2004-12-16

Similar Documents

Publication Publication Date Title
AU2003901345A0 (en) Improved cannula
AU2003291579A1 (en) Yield improvement
AU2003242239A1 (en) Cosmetic preparation
AU2003255398A1 (en) Lipid preparation, particularly cosmetic preparation
AU2003292263A1 (en) Use of substituted 2-phenylbenzimidazoles as medicaments
IL175369A0 (en) Novel compound, corresponding compositions, preparation and/or treatment methods
WO2005110009A8 (en) COMPOSITIONS AND METHODS RELATING TO TSP-30a, b, c AND d
AU2003901897A0 (en) Conjugate
AU2003249114A1 (en) Cosmetic composition
AU2003303744A1 (en) Novel nimesulide compositions
AU2003260943A1 (en) Improved novel, clear, painless preparation of propofol
AU2003900505A0 (en) Anthelmintic composition
AU2003243972A1 (en) External preparation for improving coital function
AU2002953252A0 (en) Compositions, Compounds and Methods for their Preparation
AU2003289718A1 (en) Cosmetic preparation
AU2003304178A1 (en) Preparation method of valienamine using solid catalysts
AU2003304563A1 (en) Preparation of molecular sieve used for the dehydration of the alcohol
AU2003205355A1 (en) Methods of administering gaultherin-containing compositions
AU2003215633A1 (en) Hair treatment compositions
AU2002346304A1 (en) Solid cosmetic preparation
AU2003289640A1 (en) Tricyclacetalactonin, Preparation and Use there of
AU2003209662A1 (en) Novel form of simvastatin.
AU2003900577A0 (en) Medical composition
AU2003266526A1 (en) Medicinal composition
AU2003901020A0 (en) Improvement to catalysators

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase